Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation

Jeff C Liu1, Dong-Yu Wang2,3, Sean E Egan4,5

  • 1Division of Advanced Diagnostics, Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.

Oncotarget
|January 28, 2016
PubMed

Insights

Loss of PTEN and activation of PIK3CA both increase phosphatidylinositol (3, 4, 5)-trisphosphate) (PIP3) levels in mouse mammary tumors. These genetic changes result in distinct cancer signaling profiles, potentially affecting tumor development and treatment response.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • PTEN loss and PIK3CA activation are common in cancer, both leading to increased phosphatidylinositol (3, 4, 5)-trisphosphate (PIP3) signaling.
  • Distinct biochemical functions of PTEN and PIK3CA beyond PIP3 regulation are not well understood in vivo.

Purpose of the Study:

  • To directly compare cancer signaling in mammary tumors with PTEN loss versus PIK3CA activation in mice.
  • To elucidate the in vivo consequences of PTEN loss and PIK3CA activation beyond PIP3 regulation.

Main Methods:

  • Utilized MMTV-Cre:Ptenf/f and MMTV-Cre:Pik3ca(LSL-H1047R) mouse models for mammary tumor generation.
  • Employed unsupervised hierarchical clustering to analyze tumor subtypes.
  • Conducted Gene Set Enrichment Analysis (GSEA) to compare signaling pathway profiles.

Main Results:

  • MMTV-Cre:Pik3ca(LSL-H1047R) tumors segregated into two distinct groups: squamous-likeEx and class14(Ex).
  • MMTV-Cre:Ptenf/f tumors clustered with PIK3CA(H1047R) class14(Ex) tumors, showing a 'luminal' expression profile.
  • GSEA revealed similar signaling pathway profiles between Pten(Δ) and PIK3CA(H1047R) class14(Ex) tumors, with notable differences in PI3K and EGFR signaling.

Conclusions:

  • PTEN loss and PIK3CA activation in mammary tumors lead to distinct, discernible signaling differences.
  • These differences in cancer signaling may influence tumorigenesis and response to cancer therapies.
  • Further investigation into these distinct pathways is warranted for therapeutic targeting.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K